Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms. How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase). We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium. Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3j3 (GSK-313), which regulates cell fate determination in diverse organisms including Dictyostelium, Drosophila, and Xenopus. Lithium potently inhibits GSK-313 activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases. In support of this hypothesis, lithium treatment phenocopies loss of GSK-3j8 function in Xenopus and Dictyostelium. These observations help explain the effect of lithium on cell-fate determination and could provide insights into the pathogenesis and treatment ofbipolar disorder.
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Lithium has a profound effect on the development of diverse organisms, including Dictyostelium, sea urchins, zebrafish, and Xenopus (1) (2) (3) (4) (5) . In Dictyostelium, lithium alters cell fate by blocking spore cell and promoting stalk cell development (1, 2) . In Xenopus, lithium causes an expansion of dorsal mesoderm, leading to duplication of the dorsal axis or, in extreme cases, entirely dorsalized embryos lacking identiflably ventral tissues (3) . Lithium also mimics insulin by stimulating glycogen synthesis (6) and is the most effective treatment for bipolar disorder (7, 8) .
Several hypotheses have been advanced to explain the mechanism of lithium action, yet its molecular target in cell-fate determination and glycogen metabolism, as well as in the treatment of bipolar disorder, remains unclear (7) (8) (9) (10) . The most widely accepted model, the inositol depletion hypothesis, is based on the observation that lithium inhibits inositol monophosphatase (IMPase) and could thereby deplete the cell of an endogenous source of inositol (9, 11) . Cells would become unable to generate inositol 1,4,5 trisphosphate (InsP3) in response to extracellular signals and thus InsP3-dependent responses would be blocked. In support of this hypothesis, microinjection of myo-inositol can prevent the effect of lithium inXenopus (12) , although this requires the coinjection of a high concentration of myo-inositol (0.3 M) with lithium (also at 0.3 M). However, the inositol depletion hypothesis does not explain why lithium alters cell fate in Dictyostelium discoideum, since mutants lacking the gene for phospholipase C, and thus unable to generate InsP3 in response to extracellular signals, develop normally (13) . It also does not explain simply the effect of lithium on glycogen synthesis or on cells that have an exogenous source of inositol.
A class of bisphosphonate compounds that are =1000-fold more potent than lithium in inhibiting IMPase has recently become available (14, 15) . Using these inhibitors, we have reexamined the role of IMPase in the early development of Xenopus. We show here that complete inhibition of IMPase has no discernible effect on the morphogenesis of Xenopus embryos, ruling out this enzyme as the target of lithiuminduced teratogenesis.
An alternative target of lithium is suggested by the close similarity between lithium action and the effect of ectopic expression of wnt genes in Xenopus embryos (3, 16 
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Developmental Biology: Klein and Melton added and the incubation was continued for 25 min. Samples were then diluted with 1.0 ml of 0.1 x MMR, boiled for 5 min, and applied to Dowex columns as described (25) . Inositol was present in the flow-through and inositol-1-phosphate was eluted by application of 3 ml of 0.1 M formic acid/1.5 M ammonium formate (25) ix a , mM LiCl. Lysates were prepared and applied to Dowex columns as above.
GSK-38 Activity. GSK-33 was obtained from New England
Biolabs and assayed according to the supplier's protocol using 0.5-1.0 unit of GSK-33 per assay. The peptide substrate (GS-2) was present at 25 ,uM and'incorporation of 32p was measured by binding to P81 paper'according to previously described methods (26) . The peptide was synthesized with phosphate incorporated into the serine closest to the C terminus and had the sequence RPASYPPSPSLSRHSSPHQS(P)EDEEE (27) . I-2 was present at 50 ,ug/ml and T was 25 (14) . As shown in Fig.  1 (Fig. 1B) . However, microinjection of L-690,330, in contrast to lithium, does not dorsalize embryos ( Fig. 1C ; n = 55) and has no discernible effect on development (at the highest injected doses mild nonspecific toxicity was observed, data not shown). These data show that inhibition of IMPase does not explain the effect of lithium on Xenopus development.
Because dorsalization by lithium is remarkably similar to ectopic expression of wingless/int-1 related genes (wnt) in Xenopus embryos (16), we have tested whether lithium might act on a component of the wnt signaling pathway. This pathway, which appears to be well conserved between vertebrates and invertebrates (21) (22) (23) 28) , is inhibited in Drosophila by zeste white 3/shaggy (zw3/sgg), the homologue of the mammalian enzyme GSK-3,3. Although GSK-3p3 was first described as an inhibitor of glycogen synthase (17, 29) , it is likely that it regulates distinct substrates in other signal transduction pathways (17) , including the wnt pathway. A central role has also been demonstrated for this gene in the development of diverse organisms including Dictyostelium and Xenopus (20) (21) (22) (23) . Therefore, we wished to test whether lithium acts by inhibiting GSK-3,B directly, as this would be predicted to mimic wnt signaling.
To test our hypothesis, purified GSK-3f3 was assayed by using a peptide substrate (27, 30) and was found to be inhibited by lithium chloride with 50% inhibition (IC5o) at 2 mM ( Fig.   2A ). Little inhibition of phosphorylation was seen with NaCl, KCl, NH4Cl, or CsCl at 20 mM (Fig. 2B) , while lithium acetate showed inhibition nearly identical to LiCl (Fig. 2B and data not shown), indicating that the inhibition is mediated specifically by lithium ion and not by other monovalent cations or by chloride. LiCl inhibited GSK-3f3-mediated phosphorylation of protein substrates, including protein phosphatase inhibitor-2 (31) and T protein (32, 33) with an IC50 also near 2 mM (Fig.   3A , data not shown). Inhibition of GSK-3f3 is observed at concentrations well within the therapeutic range for lithium (0.5-1.5 mM) in the treatment of mania. In Xenopus, the effective internal concentration after lithium treatment is not known precisely but reaches a maximum of -8-9 mM (12) .
The specificity of lithium inhibition was tested by assaying other protein kinases, including PKA, ERK-1/MAP kinase, and CKII, under similar conditions. Thus, at 20 mM lithium, PKA shows full activity toward kemptide (Fig. 3B) and casein (not shown). Similarly, lithium shows minimal inhibition of ERK-1/MAP kinase-mediated phosphorylation of myelin basic protein and CKII phosphorylation of casein (Fig. 3) . These data indicate that lithium is not a general inhibitor of protein kinases in this dose range.
The kinetic nature of the inhibition of GSK-3,B by lithium was investigated by measuring initial velocity as a function of substrate concentration at several concentrations of LiCl. The data, presented as double reciprocal plots (Fig. 4) , show that the greatest effect is on the apparent Vm, and the plot of 1/Vmax (y-intercept) versus lithium concentration is linear (not shown), suggesting that lithium acts as an uncompetitive inhibitor of GSK-33. (Ki for LiCl = 2.1 + 0.6 mM). Thus, inhibition of GSK-3,3 by lithium should not be overcome by increasing substrate concentration. The inhibition of IMPase by lithium is also uncompetitive (Ki = 0.8 mM), and it has been argued that this is an important feature for its therapeutic utility (9, 11) since the degree of inhibition is proportional to the concentration of substrate.
The hypothesis that GSK-3, is the endogenous target of lithium action is supported by genetic data as well as in vivo biochemical data. Thus inhibition of GSK-33 activity through expression of a dominant negative mutant of GSK-3, leads to dorsalization ofXenopus embryos, similar to lithium treatment (3, (21) (22) (23) and consistent with lithium inhibiting GSK-3f. In addition, disruption of GSK-33 in Dictyostelium (gskA) diverts cells normally fated to form spores to adopt the stalk-cell lineage (20) , and this phenotype is also duplicated by lithium treatment (1) . GSK-3, was first identified in mammals as the protein kinase responsible for the inhibitory phosphorylation of glycogen synthase (17, 29) . Insulin is known to inhibit GSK-3, (30, 34) , which in turn (together with activation of protein phosphatase) leads to increased glycogen synthesis. Lithium mimics insulin action by stimulating glycogen synthesis (6), and while the mechanism remains unknown, we suggest that lithium mimics insulin by inhibiting GSK-33. Lithium has effects on numerous other organisms and it may have multiple physiological targets. However, the mechanism of lithium action in bipolar disorder remains uncertain. We propose that GSK-3f3, which is abundantly expressed in brain (40) , may serve a role in signal transduction in the brain, and that lithium inhibition of this pathway could explain its actions in manic-depressive illness in addition to its effects on development and its insulin-like activity.
